The 7th Annual LD Micro Invitational on June 7 & the 2017 Marcum MicroCap Conference on June 16

ANN ARBOR, MI / ACCESSWIRE / May 31, 2017 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ: NDRAU), a developer of photo- and thermo-acoustic medical technologies, has been invited to participate at two upcoming conferences in June 2017.

The 7th Annual LD Micro Invitational is being held on June 6-7, 2017 at the Luxe Sunset Boulevard Hotel in Los Angeles. ENDRA CEO, Francois Michelon, and CFO, David Wells, are scheduled to present on Wednesday, June 7 at 10:30 a.m. Pacific time with one-on-one meetings held throughout the conference. For additional information or to schedule a one-on-one meeting with ENDRA management, please log-in via the link provided in your invitation. You may also email your request to NDRA@mzgroup.us or call Chris Tyson at (949) 491-8235.

The 2017 Marcum MicroCap Conference is being held on June 15-16, 2017 at the Grand Hyatt Hotel in New York City. ENDRA CEO, Francois Michelon, and CFO, David Wells, are scheduled to present on Friday, June 16 at 10:30 a.m. Eastern time with one-on-one meetings held throughout the conference. For additional information or to schedule a one-on-one meeting with ENDRA management, please log-in via the link provided in your invitation. You may also email your request to NDRA@mzgroup.us or call Chris Tyson at (949) 491-8235.

About the 7th Annual LD Micro Invitational

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event). In 2015, LD Micro launched ldmicro.com as a portal to provide exclusive intraday information on the entire sector, including the first pure microcap index (LDMi), which covers stocks in North American with market capitalizations between $50M-$300M. It is a non-registered investment advisor. For more details, please click here.

About the 2017 Marcum MicroCap Conference

The Marcum MicroCap Conference is an annual highlight on the investment community calendar. Since its launch in 2012, this event has become a nationally recognized forum for publicly traded companies with less than $500 million in market capitalization to network with fund managers and high net worth investors who focus on small cap equities. More than 2,000 participants from all segments of the microcap market participate each year, including senior management, finance and legal executives, venture and lower middle-market private equity investors, institutional investors, directors, investment bankers, buy- and sell-side analysts, and service providers to the microcap marketplace. The agenda will feature presentations by CEOs and CFOs in seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity for investors to meet with management of presenting companies on a one-on-one basis. For more information, please click here.

About ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ: NDRAU) is a developer of photo- and thermo-acoustic medical technologies bringing new capabilities to existing ultrasound systems. ENDRA's photo-acoustic solutions currently help global medical researchers screen and modify disease models with high image quality and volume scanning speed. ENDRA has a global installed base of leading institutions using the Nexus-128 system, the only commercially available 3D imaging system for imaging anatomy, physiology and labeled molecular targets. ENDRA's thermo-acoustic technology is being developed to enable clinicians to use their existing ultrasound equipment to visualize tissue function, composition, and monitor a variety of therapeutic interventions - at the point of care. This directly aligns with current healthcare trends to improve patient access, clinical effectiveness, safety and cost. For more information, please visit www.endrainc.com. Social media coverage on ENDRA's May 9, 2017 IPO can be found here on Twitter, here on Facebook and here on LinkedIn.

Company Contact:
David Wells
Chief Financial Officer
(734) 997-0464
investors@endrainc.com
www.endrainc.com

Media & Investor Relations Contact:
MZ North America
Chris Tyson
Managing Director
(949) 491-8235
NDRA@mzgroup.us
www.mzgroup.us

SOURCE: ENDRA Life Sciences Inc.